BioCentury
ARTICLE | Clinical News

THN102: Ph II started

November 2, 2016 5:59 PM UTC

Theranexus began a double-blind, placebo-controlled, 3-way crossover, French Phase II trial to compare 300 mg oral modafinil plus 3 and 27 mg oral flecainide vs. 300 mg modafinil alone in 2-weeks peri...

BCIQ Company Profiles

Theranexus S.A.